Intranasal sertraline for the investigation of nose-to-brain delivery to mitigate systemic exposure
Shoshana C. Williams, Travis C. Lantz, Vanessa M. Doulames…·Eric Andrew Appel
This study develops intranasal sertraline formulations to reduce systemic exposure while maintaining brain delivery, showing comparable brain exposure at half the dose compared to oral administration in mice.